Search Results - "Damm, Georg"

Refine Results
  1. 1
  2. 2

    Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis by Seidemann, Lena, Krüger, Anne, Kegel-Hübner, Victoria, Seehofer, Daniel, Damm, Georg

    Published in Molecules (Basel, Switzerland) (22-02-2021)
    “…Nonalcoholic fatty liver disease (NAFLD) is among the leading causes of end-stage liver disease. The impaired hepatic lipid metabolism in NAFLD is exhibited by…”
    Get full text
    Journal Article
  3. 3

    A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells by Klein, Marcus, Thomas, Maria, Hofmann, Ute, Seehofer, Daniel, Damm, Georg, Zanger, Ulrich M

    Published in Drug metabolism and disposition (01-02-2015)
    “…Inflammatory processes are associated with compromised metabolism and elimination of drugs in the liver, largely mediated by proinflammatory cytokines, such as…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Featured Article: Isolation, characterization, and cultivation of human hepatocytes and non-parenchymal liver cells by Pfeiffer, Elisa, Kegel, Victoria, Zeilinger, Katrin, Hengstler, Jan G, Nüssler, Andreas K, Seehofer, Daniel, Damm, Georg

    “…Primary human hepatocytes (PHH) are considered to be the gold standard for in vitro testing of xenobiotic metabolism and hepatotoxicity. However, PHH…”
    Get full text
    Journal Article
  6. 6

    Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress by Rennert, Christiane, Heil, Theresa, Schicht, Gerda, Stilkerich, Anna, Seidemann, Lena, Kegel-Hübner, Victoria, Seehofer, Daniel, Damm, Georg

    “…Overweight has become a major health care problem in Western societies and is accompanied by an increasing incidence and prevalence of non-alcoholic fatty…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Involvement of sphingosine 1-phosphate in palmitate-induced insulin resistance of hepatocytes via the S1P2 receptor subtype by Fayyaz, Susann, Henkel, Janin, Japtok, Lukasz, Krämer, Stephanie, Damm, Georg, Seehofer, Daniel, Püschel, Gerhard P., Kleuser, Burkhard

    Published in Diabetologia (01-02-2014)
    “…Aims/hypothesis Enhanced plasma levels of NEFA have been shown to induce hepatic insulin resistance, which contributes to the development of type 2 diabetes…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Immuno-inflammatory in vitro hepatotoxicity models to assess side effects of biologicals exemplified by aldesleukin by Roser, Luise A, Luckhardt, Sonja, Ziegler, Nicole, Thomas, Dominique, Wagner, Pia Viktoria, Damm, Georg, Scheffschick, Andrea, Hewitt, Philip, Parnham, Michael J, Schiffmann, Susanne

    Published in Frontiers in immunology (17-11-2023)
    “…Hepatotoxicity induced by immunotherapeutics is an appearing cause for immune-mediated drug-induced liver injury. Such immuno-toxic mechanisms are difficult to…”
    Get full text
    Journal Article
  15. 15

    Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity by Ruoß, Marc, Damm, Georg, Vosough, Massoud, Ehret, Lisa, Grom-Baumgarten, Carl, Petkov, Martin, Naddalin, Silvio, Ladurner, Ruth, Seehofer, Daniel, Nussler, Andreas, Sajadian, Sahar

    “…Although human liver tumor cells have reduced metabolic functions as compared to primary human hepatocytes (PHH) they are widely used for pre-screening tests…”
    Get full text
    Journal Article
  16. 16

    Direct transcriptional regulation of human hepatic cytochrome P450 3A4 (CYP3A4) by peroxisome proliferator-activated receptor alpha (PPARα) by Thomas, Maria, Burk, Oliver, Klumpp, Britta, Kandel, Benjamin A, Damm, Georg, Weiss, Thomas S, Klein, Kathrin, Schwab, Matthias, Zanger, Ulrich M

    Published in Molecular pharmacology (01-03-2013)
    “…The nuclear receptor peroxisome proliferator-activated receptor (PPAR)α is known primarily as a regulator of fatty acid metabolism, energy balance, and…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Primary-like Human Hepatocytes Genetically Engineered to Obtain Proliferation Competence as a Capable Application for Energy Metabolism Experiments in In Vitro Oncologic Liver Models by Scheffschick, Andrea, Babel, Jonas, Sperling, Sebastian, Nerusch, Julia, Herzog, Natalie, Seehofer, Daniel, Damm, Georg

    Published in Biology (Basel, Switzerland) (09-08-2022)
    “…Non-alcoholic fatty liver disease (NAFLD), characterized by lipid accumulation in the liver, is the most common cause of liver diseases in Western countries…”
    Get full text
    Journal Article
  19. 19

    Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-Matrigel matrices by Seidemann, Lena, Prinz, Sarah, Scherbel, Jan-Constantin, Götz, Christina, Seehofer, Daniel, Damm, Georg

    Published in EXCLI journal (2023)
    “…Loss of differentiation of primary human hepatocytes (PHHs) is a known problem of liver models. Culture optimizations using collagen type I and Matrigel reduce…”
    Get full text
    Journal Article
  20. 20

    Resveratrol differentially regulates NAMPT and SIRT1 in Hepatocarcinoma cells and primary human hepatocytes by Schuster, Susanne, Penke, Melanie, Gorski, Theresa, Petzold-Quinque, Stefanie, Damm, Georg, Gebhardt, Rolf, Kiess, Wieland, Garten, Antje

    Published in PloS one (06-03-2014)
    “…Resveratrol is reported to possess chemotherapeutic properties in several cancers. In this study, we wanted to investigate the molecular mechanisms of…”
    Get full text
    Journal Article